BAX 855: Clinical Trials

7 trials of BAX 855, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed. 7 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 37Completed 7
Phase 21Completed 1

Follow BAX 855: new trials by email Literature Review of BAX 855 trials Research Report on BAX 855

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Adynovate in Previously Treated Chinese Teenagers and Adults With Severe Hemophilia A
Adynovate - Hemophilia A
Phase 3CompletedTakeda372023-03-272025-05-01
BAX 855 PK-guided Dosing
PEGylated Recombinant Factor VIII - Hemophilia A
Phase 3CompletedBaxalta now part of Shire1352015-11-232021-05-25
A Study of PEGylated Recombinant Factor VIII (BAX855) in Previously Untreated Young Children With Severe Hemophilia A
PEGylated Recombinant Factor VIII, ITI - Hemophilia A
Phase 3CompletedBaxalta now part of Shire1202015-11-122025-07-28
BAX 855 Pediatric Study
Antihemophilic Factor (Recombinant) - Plasma/Albumin Free Method, PEGylated Recombinant Factor VIII - Hemophilia A
Phase 3CompletedBaxalta now part of Shire752014-10-312021-05-24
Phase 3 Efficacy and Safety Study of BAX 855 in Severe Hemophilia A Patients Undergoing Surgical Procedures
PEGylated Recombinant factor VIII (rFVIII) - Hemophilia A
Phase 3CompletedBaxalta now part of Shire302013-12-202021-05-24
BAX 855 Continuation
BAX855 - Hemophilia A
Phase 3CompletedBaxalta now part of Shire2182013-10-152021-05-24
Study Investigating a PEGylated Recombinant Factor VIII (BAX 855) for Hemophilia A (PROLONG-ATE Study)
Antihemophilic Factor (Recombinant) - Plasma/Albumin Free Method, PEGylated Recombinant Factor VIII - Hemophilia A
Phase 2 / Phase 3CompletedBaxalta now part of Shire1592013-01-312021-05-20

Conditions studied

Hemophilia A (7)

Sponsors

Baxalta now part of Shire (6)  ·  Takeda (1)

Countries

Bulgaria (6)  ·  Spain (6)  ·  Ukraine (6)  ·  United Kingdom (6)  ·  United States (6)  ·  Malaysia (5)  ·  Netherlands (5)  ·  Taiwan (5)  ·  Austria (4)  ·  Germany (4)  ·  Hong Kong (4)  ·  South Korea (4)  ·  Switzerland (4)  ·  Turkey (Türkiye) (4)  ·  Australia (3)

Results publications

PMID 26157075, PMID 27328112, PMID 27891721, PMID 33150384, PMID 36655343, PMID 37465396, PMID 37646148

NIH funding

2014 (2), 2015 (1), 2023 (1)